[ad_1]
See – monitor
Millions of healthy people take a small daily dose of aspirin to reduce the risk of heart attack or stroke, but more and more studies have questioned the ## 147 ## 39 effectiveness of this preventive measure.
More and more studies, especially since last year, have shown the risks of aspirin, which are not mentioned frequently.
This medicine, found in many homes, can cause bleeding. A new analysis published in the Journal of the American Medical Association (gamma) showed that the benefits of aspirin for cardiovascular health in healthy people are offset by an increased risk of bleeding, particularly brain and intestines.
"There is no reason for healthy people to take regular aspirin," Xun Zheng, a cardiology doctor, told AFP at Kings College London.
"Our data shows that there is a real danger," he said. "People should not take this medicine as harmless." However, the risks are very low: cardiovascular diseases are very rare in people with no history and bleeding in the case of aspirin.
According to the analysis, among the 265 people treated with aspirin over five years, only one heart attack problem will be avoided. However, one out of every 210 patients treated with aspirin will have a dangerous haemorrhage.
These figures are not at all important for the cardiologist. But the researchers say these figures are important for the entire population, especially in the United States, where a study conducted in 2015 showed that 47% of Americans are in good health and are taking care of themselves. aspirin.
Aspirin causes sepsis that prevents clotting and thus reduces the risk of heart attack or stroke.
For people who have already experienced such problems, taking a small dose of aspirin a day is good because the chance of preventing a new stroke is greater than the risk of bleeding.
But the controversy concerns people who have no precedent with a low probability of injury or difficulty identifying the risk.
In the United States, the highly recommended US Prosecution Service Working Group recommends taking aspirin for those 50 years of age who have a 10% chance of having an aspirin. heart attack or stroke in the next 10 years. In Europe, aspirin is only recommended for people who have ever had a heart attack.
The results of three major clinical trials published in 2018 contrast with US recommendations. She concluded that this drug is not helpful but is harmful to people who are not at high risk for people with diabetes. The risk of internal hemorrhage preoccupies the seventies.
The new global scan examined 13 clinical trials conducted between 1998 and 2018 and found extracts based on all trials involving 164,000 people. Doctors said that aspirin should be a priority to reduce cardiovascular risk, including quitting, exercise and improving nutrition … Then, the case of each patient can be examined to see if it is useful or not for aspirin.
But the analysis revealed no connection to cancer, while several recent studies have concluded that aspirin reduces cancer, especially colon cancer.
[ad_2]
Source link
